These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8296736)

  • 41. [Treatment of cardiogenic shock with thrombolysis and coronary angioplasty].
    Roqué M; Sanz GA
    Rev Esp Cardiol; 1992; 45 Suppl 2():43-9. PubMed ID: 1475508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Case 3: Elderly female patient with acute myocardial infarction presenting sudden shock during thrombolytic treatment.
    Bittencourt MS; Staniak HL; Aiello VD
    Arq Bras Cardiol; 2010 Jun; 94(6):132-8. PubMed ID: 20625635
    [No Abstract]   [Full Text] [Related]  

  • 43. Percutaneous coronary intervention for acute MI does not prevent in-hospital development of cardiogenic shock compared to fibrinolysis.
    Lindholm MG; Boesgaard S; Thune JJ; Kelbaek H; Andersen HR; Kober L;
    Eur J Heart Fail; 2008 Jul; 10(7):668-74. PubMed ID: 18571985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiogenic shock: thrombolysis or angioplasty?
    Chou TM; Amidon TM; Ports TA; Wolfe CL
    J Intensive Care Med; 1996; 11(1):37-48. PubMed ID: 10160069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Stimulating and hypobiotic therapy in cardiogenic shock].
    Bobrov VA; Shved NI; Sherman DM
    Lik Sprava; 1994; (5-6):7-12. PubMed ID: 7831916
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK trial.
    Zeymer U; Tebbe U; Weber M; Vohringer HF; Jaksch R; Bischoff KO; Toepel W; Marsalek P; Horn S; Neuhaus KL;
    J Invasive Cardiol; 2003 Jul; 15(7):385-9. PubMed ID: 12840235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Successful use of levosimendan in a patient with cardiogenic shock complicating acute myocardial infarction].
    Mustapha F; Moufida H; Nedia B; Anis L; Iheb L; Habib H
    Tunis Med; 2005 Oct; 83(10):635-7. PubMed ID: 16370217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point.
    Braunwald E; Cannon CP; McCabe CH
    Circulation; 1992 Aug; 86(2):683-7. PubMed ID: 1638732
    [No Abstract]   [Full Text] [Related]  

  • 49. Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial.
    Ohman EM; Nanas J; Stomel RJ; Leesar MA; Nielsen DW; O'Dea D; Rogers FJ; Harber D; Hudson MP; Fraulo E; Shaw LK; Lee KL;
    J Thromb Thrombolysis; 2005 Feb; 19(1):33-9. PubMed ID: 15976965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interventional management of cardiogenic shock.
    Webb JG
    Can J Cardiol; 1998 Feb; 14(2):233-44. PubMed ID: 9520860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?
    Sjauw KD; Engström AE; Vis MM; van der Schaaf RJ; Baan J; Koch KT; de Winter RJ; Piek JJ; Tijssen JG; Henriques JP
    Eur Heart J; 2009 Feb; 30(4):459-68. PubMed ID: 19168529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Therapy of cardiogenic shock in acute myocardial infarct].
    Görge G; Haude M; Baumgart D; Sack S; Ge J; Leischik R; Erbel R
    Herz; 1994 Dec; 19(6):360-70. PubMed ID: 7843692
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Parenteral antiplatelet therapy in acute myocardial infarction complicated by cardiogenic shock - A field still worthy of future randomized trials?
    Tralhão A
    Rev Port Cardiol; 2023 Feb; 42(2):121-123. PubMed ID: 36115802
    [No Abstract]   [Full Text] [Related]  

  • 54. Delays in thrombolytic therapy for acute myocardial infarction in Finland. Results of a national thrombolytic therapy delay study. Finnish Hospitals' Thrombolysis Survey Group.
    Hirvonen TP; Halinen MO; Kala RA; Olkinuora JT
    Eur Heart J; 1998 Jun; 19(6):885-92. PubMed ID: 9651712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial.
    ; Alexander JH; Reynolds HR; Stebbins AL; Dzavik V; Harrington RA; Van de Werf F; Hochman JS
    JAMA; 2007 Apr; 297(15):1657-66. PubMed ID: 17387132
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Delayed thrombolysis in a patient presenting after 12 hours of chest pain, cardiogenic shock and life-threatening arrhythmias.
    Falcon-Chevere JL; Mercado-Alvarado JJ; Ramos-Arias Y; Cabañas-Rivera JG
    Bol Asoc Med P R; 2009; 101(3):54-7. PubMed ID: 20120988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Therapy of cardiogenic shock due to myocardial infarction].
    Nonogi H
    Nihon Naika Gakkai Zasshi; 1996 Jan; 85(1):54-9. PubMed ID: 8871309
    [No Abstract]   [Full Text] [Related]  

  • 58. Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial.
    Singh M; White J; Hasdai D; Hodgson PK; Berger PB; Topol EJ; Califf RM; Holmes DR
    J Am Coll Cardiol; 2007 Oct; 50(18):1752-8. PubMed ID: 17964038
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries.
    Hasdai D; Holmes DR; Topol EJ; Berger PB; Criger DA; Hochman JS; Bates ER; Vahanian A; Armstrong PW; Wilcox R; Ohman EM; Califf RM
    Eur Heart J; 1999 Jan; 20(2):128-35. PubMed ID: 10099909
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction.
    Hochman JS; Sleeper LA; Webb JG; Dzavik V; Buller CE; Aylward P; Col J; White HD;
    JAMA; 2006 Jun; 295(21):2511-5. PubMed ID: 16757723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.